Revive Therapeutics Ltd (RVV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21 | 15 | 46 | 55 | 273 |
| Receivables | 6 | 0 | 0 | 1 | 13 |
| Other current assets | 10 | 10 | 10 | 20 | 20 |
| TOTAL | $113 | $68 | $112 | $202 | $529 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | 1 | 1 |
| Investments And Advances | 136 | 136 | 137 | 134 | 140 |
| Intangibles | N/A | 0 | 9,378 | 9,378 | 9,378 |
| TOTAL | $137 | $137 | $9,516 | $9,513 | $9,519 |
| Total Assets | $250 | $205 | $9,628 | $9,715 | $10,048 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,764 | 2,648 | 2,707 | 2,571 | 2,572 |
| Accrued Expenses | 838 | 866 | 830 | 666 | 638 |
| TOTAL | $3,602 | $3,514 | $3,537 | $3,238 | $3,210 |
| Non-Current Liabilities | |||||
| Long Term Debt | 68 | 67 | 66 | N/A | N/A |
| Other Non-Current Liabilities | 81 | 80 | 83 | 83 | 79 |
| TOTAL | $149 | $147 | $148 | $83 | $79 |
| Total Liabilities | $3,751 | $3,661 | $3,686 | $3,321 | $3,289 |
| Shareholders' Equity | |||||
| Common Shares | 47,858 | 47,699 | 47,500 | 47,500 | 47,500 |
| Retained earnings | -77,479 | -77,198 | -67,601 | -67,024 | -66,659 |
| Other shareholders' equity | 2,435 | 2,408 | 2,408 | 2,408 | 2,408 |
| TOTAL | $-3,501 | $-3,456 | $5,942 | $6,395 | $6,759 |
| Total Liabilities And Equity | $250 | $205 | $9,628 | $9,715 | $10,048 |